Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway
ASXL1 mutations are frequently found in age-related clonal haemaotopoiesis (CH), but how they drive CH is unclear. Here the authors show that expression of C-terminal truncated ASXL1 in haematopoietic stem cells (HSCs) leads to Akt de-ubiquitination, activated Akt/mTOR signaling, and aberrant HSC pr...
Guardado en:
Autores principales: | Takeshi Fujino, Susumu Goyama, Yuki Sugiura, Daichi Inoue, Shuhei Asada, Satoshi Yamasaki, Akiko Matsumoto, Kiyoshi Yamaguchi, Yumiko Isobe, Akiho Tsuchiya, Shiori Shikata, Naru Sato, Hironobu Morinaga, Tomofusa Fukuyama, Yosuke Tanaka, Tsuyoshi Fukushima, Reina Takeda, Keita Yamamoto, Hiroaki Honda, Emi K. Nishimura, Yoichi Furukawa, Tatsuhiro Shibata, Omar Abdel-Wahab, Makoto Suematsu, Toshio Kitamura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5a4339b6caee4c1d9bbb984e54dddbf0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Shuhei Asada, et al.
Publicado: (2018) -
Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia
por: Yasutaka Hayashi, et al.
Publicado: (2019) -
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
por: Jean-Baptiste Micol, et al.
Publicado: (2017) -
Loss of Asxl2 leads to myeloid malignancies in mice
por: Jianping Li, et al.
Publicado: (2017) -
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1
por: Salima Daou, et al.
Publicado: (2018)